Pfizer Public Policy
At Pfizer, public policy is part of the way we relate to the many people who have a stake in our company and our pharmaceutical products: patients, physicians, insurers, employers, Pfizer shareholders and employees, journalists, and policy makers. Engaging in public policy debates is part of our responsibility, because effective public policies can help create an environment in which innovative new prescription medicines are brought to market, and patients are able to receive the medicines they need.
We invite you to browse through the Public Policy section of this Web site to learn about our positions on important health care issues and find more in-depth information designed for those interested in taking a closer look at the issues.
In This Section
Access and Affordability
Learn about what Pfizer is doing to improve patients' access to high quality health care and Pfizer's medications.
Pricing and Value
Find information about the value pharmaceuticals offer and why Pfizer believes it is critical to maintain public policies that encourage investment in the development of new treatments and cures.
Health Care Reform
Find out what Pfizer is doing to help improve health care in the U.S.
Resources
For your convenience, where possible, resources cited throughout the Pfizer public policy site have been posted in this section.
Pfizer is committed to engaging in public policy debate to help to continually improve the pharmaceutical industry and increase access to prescription medicine for people around the world.
Last Updated September 2007
If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page. |
Learn more about our commitments and performance in the area of corporate responsibility.
Learn more about our progress in building a foundation for solid, sustainable growth and
our promise to continue
as a leader in meeting
one of the world's most basic needs: better health care for more people.
From laboratory to medicine cabinet
Follow Pat the Pill™ on his journey to learn more about new medicines including where they come from, how they're tested for safety, and why generics are cheaper than brand name drugs.

